Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

30.0%

3 terminated/withdrawn out of 10 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT03886077Completed

Study of Hepatitis Eradication Receiving Protease Inhibitor Administration

Role: lead

NCT03147430Active Not Recruiting

Early Detection of Breast Cancer in Women With Suspicious Mammograms

Role: lead

NCT03437395Not ApplicableActive Not Recruiting

Accelerated Partial Breast Irradiation Study

Role: lead

NCT05080504Completed

Heart Failure Monitoring With Eko Electronic Stethoscopes (CardioMEMS)

Role: collaborator

NCT03760263Phase 4Completed

Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus

Role: lead

NCT03148015Completed

Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)

Role: lead

NCT00593905Withdrawn

Pharmacogenomics in Pulmonary Arterial Hypertension

Role: collaborator

NCT03980366Not ApplicableTerminated

Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders

Role: collaborator

NCT04130607Not ApplicableCompleted

A Study to Evaluate Strategies for Teaching Effective Use of Diagnostic Tests

Role: lead

NCT02028325Phase 4Terminated

Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions

Role: collaborator

All 10 trials loaded